HGF’s pharmaceutical practice brings together one of he largest and most talented collection of specialist patent attorney in Europe. The majority of our attorneys have advanced degrees and many years’ experience in large multinational pharmaceutical companies where they built, managed, commercialised and defended global patent portfolios for some of the most successful, high profile and improtant medicines around the world.
Our multidisciplinary team supports clients through all stages of the development and lifespan of pharmaceutical products. We specialise in providing IP strategy advice, patent prosecution, invention capture, drafting and filing patent applications, infringement analysis, EPO oppositions/appeals and, in conjunction with our IP litigators, multi-jurisdictional patent litigation for both owners and challengers. In addition to this we have specialist experience of supplementary protection certificates (SPCs), regulatory data exclusivity and IP due diligence. A large part of HGF’s pharmaceutical practice involves contentious proceedings and many of our experienced patent attorneys specialise in opposition and appeal proceedings before the European Patent Office. We are regularly involved with complex and high-value multi-party oppositions.
Our technical expertise covers drug compounds, particular forms of drug compounds (salt, solvates and polymorphs), formulations (including advanced drug delivery systems), processes for making drug compounds, methods of treatment and therapeutic uses (including drug repositioning), dosage regimens, combination therapies, drug conjugates (such as antibody drug conjugates and PROTACs) and neutraceuticals.
Join our webinar on 1st December, where speakers from Shiga, one of the leading IP firms in Japan, will present on ‘Patent eligibility of AI-related pharmaceutical inventions and practical tips …Event details
HGF and Knobbe Martens are holding a webinar on 3rd November. Challenging granted patents: a comparison between Europe and the US In this webinar we will compare and contrast mechanisms …Event details
The IAM Patent 1000 – the world’s leading patent professionals 2021 guide has now been published. HGF has 18 European attorneys listed. IAM Patent 1000 is a unique guide that …Read article
World Intellectual Property Day is on 26th April. This year’s theme is IP & SME’s: Taking your ideas to market. World IP day 2021 shines a light on the critical role of …Event details
HGF is attending IQPC Global IP Exchange Europe 2021 virtual event being held 9 – 10 March 2021. The Global IP Exchange exclusively brings together 90 expert Chief IP Counsel, Heads and …Event details
In 2021, HGF’s IP in Healthcare Conference will be delivered virtually through a series of webinars across January, February and March. The webinars will review the latest IP and related …Event details
This week, food giant Unilever announced a €1bn annual sales target for plant-based foods within the next 5-7 years, as part of its “Future Foods” program. This ambitious target is …Read article
The prevention of cancer and development of more effective strategies to detect precursors and early-stage cancers, when treatment may be most effective, remain critical societal goals. The 2020 Bionow Oncology Conference …Event details